<VariationArchive VariationID="2002273" VariationName="NM_000016.6(ACADM):c.1054_1057dup (p.Tyr353fs)" VariationType="Duplication" Accession="VCV002002273" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2051618" VariationID="2002273">
      <GeneList>
        <Gene Symbol="ACADM" FullName="acyl-CoA dehydrogenase medium chain" GeneID="34" HGNC_ID="HGNC:89" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="75724709" stop="75763679" display_start="75724709" display_stop="75763679" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="76190042" stop="76229354" display_start="76190042" display_stop="76229354" Strand="+" />
          </Location>
          <OMIM>607008</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000016.6(ACADM):c.1054_1057dup (p.Tyr353fs)</Name>
      <CanonicalSPDI>NC_000001.11:75761229:TATT:TATTTATT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="75761229" stop="75761230" display_start="75761229" display_stop="75761230" variantLength="4" positionVCF="75761229" referenceAlleleVCF="C" alternateAlleleVCF="CTATT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="76226914" stop="76226915" display_start="76226914" display_stop="76226915" variantLength="4" positionVCF="76226914" referenceAlleleVCF="C" alternateAlleleVCF="CTATT" />
      </Location>
      <ProteinChange>Y164fs</ProteinChange>
      <ProteinChange>Y317fs</ProteinChange>
      <ProteinChange>Y357fs</ProteinChange>
      <ProteinChange>Y386fs</ProteinChange>
      <ProteinChange>Y353fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.76226915_76226918dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.76226915_76226918dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.75761230_75761233dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.75761230_75761233dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007045.2" sequenceAccession="NG_007045" sequenceVersion="2" change="g.41873_41876dup">
            <Expression>NG_007045.2:g.41873_41876dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000016.6" sequenceAccession="NM_000016" sequenceVersion="6" change="c.1054_1057dup" MANESelect="true">
            <Expression>NM_000016.6:c.1054_1057dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000007.1" sequenceAccession="NP_000007" sequenceVersion="1" change="p.Tyr353fs">
            <Expression>NP_000007.1:p.Tyr353fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127328.3" sequenceAccession="NM_001127328" sequenceVersion="3" change="c.1066_1069dup">
            <Expression>NM_001127328.3:c.1066_1069dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120800.1" sequenceAccession="NP_001120800" sequenceVersion="1" change="p.Tyr357fs">
            <Expression>NP_001120800.1:p.Tyr357fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286042.2" sequenceAccession="NM_001286042" sequenceVersion="2" change="c.946_949dup">
            <Expression>NM_001286042.2:c.946_949dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001272971.1" sequenceAccession="NP_001272971" sequenceVersion="1" change="p.Tyr317fs">
            <Expression>NP_001272971.1:p.Tyr317fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286043.2" sequenceAccession="NM_001286043" sequenceVersion="2" change="c.1153_1156dup">
            <Expression>NM_001286043.2:c.1153_1156dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001272972.1" sequenceAccession="NP_001272972" sequenceVersion="1" change="p.Tyr386fs">
            <Expression>NP_001272972.1:p.Tyr386fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286044.2" sequenceAccession="NM_001286044" sequenceVersion="2" change="c.487_490dup">
            <Expression>NM_001286044.2:c.487_490dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001272973.1" sequenceAccession="NP_001272973" sequenceVersion="1" change="p.Tyr164fs">
            <Expression>NP_001272973.1:p.Tyr164fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_838" sequenceAccession="LRG_838">
            <Expression>LRG_838:g.41873_41876dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_838t1" sequenceAccession="LRG_838t1">
            <Expression>LRG_838t1:c.1054_1057dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_838p1" sequenceAccession="LRG_838p1" change="p.Tyr353Leufs">
            <Expression>LRG_838p1:p.Tyr353Leufs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000016.6(ACADM):c.1054_1057dup (p.Tyr353fs) AND Medium-chain acyl-coenzyme A dehydrogenase deficiency" Accession="RCV002820277" Version="2">
        <ClassifiedConditionList TraitSetID="944">
          <ClassifiedCondition DB="MedGen" ID="C0220710">Medium-chain acyl-coenzyme A dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16121256</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20434380</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="944" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="81" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Medium-chain acyl-coenzyme A dehydrogenase deficiency</ElementValue>
                <XRef ID="Medium-chain+acyl-coenzyme+A+dehydrogenase+deficiency/4547" DB="Genetic Alliance" />
                <XRef ID="128596003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCADD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE DEFICIENCY SECONDARY TO MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="201450" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Medium chain acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0008721" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACADMD</ElementValue>
                <XRef Type="MIM" ID="201450" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Medium-chain acyl-coenzyme A dehydrogenase (MCAD) is one of the enzymes involved in mitochondrial fatty acid ß-oxidation. Fatty acid ß-oxidation fuels hepatic ketogenesis, which provides a major source of energy once hepatic glycogen stores become depleted during prolonged fasting and periods of higher energy demands. MCAD deficiency is the most common disorder of fatty acid ß-oxidation and one of the most common inborn errors of metabolism. Most children are now diagnosed through newborn screening. Clinical symptoms in a previously apparently healthy child with MCAD deficiency include hypoketotic hypoglycemia and vomiting that may progress to lethargy, seizures, and coma triggered by a common illness. Hepatomegaly and liver disease are often present during an acute episode. Children appear normal at birth and – if not identified through newborn screening – typically present between age three and 24 months, although presentation even as late as adulthood is possible. The prognosis is excellent once the diagnosis is established and frequent feedings are instituted to avoid any prolonged periods of fasting.</Attribute>
                <XRef ID="NBK1424" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="540" />
                <XRef ID="540" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301597</ID>
                <ID Source="BookShelf">NBK1424</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/C8-C6-C10.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C8 with Lesser Elevations of C6 and C10 Acylcarnitine, Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/C8-C6-C10-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C8 Elevated + Lesser Elevations of C6 and C10, 2021</CitationText>
              </Citation>
              <XRef ID="42" DB="Orphanet" />
              <XRef ID="C0220710" DB="MedGen" />
              <XRef ID="MONDO:0008721" DB="MONDO" />
              <XRef Type="MIM" ID="201450" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5896491" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16798156|MedGen:C0220710" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003203549" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16121256</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20434380</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr353Leufs*20) in the ACADM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACADM are known to be pathogenic (PMID: 16121256, 20434380). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ACADM-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.76226914_76226915insTATT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0220710" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5896491" TraitType="Disease" MappingType="XRef" MappingValue="C0220710" MappingRef="MedGen">
        <MedGen CUI="C0220710" Name="Medium-chain acyl-coenzyme A dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

